Suggestions
Yoni Falkson
Chief Operating Officer at Gilgamesh Pharmaceuticals
Yoni Falkson is the Chief Operating Officer at Gilgamesh Pharmaceuticals, a role he has held since June 2021.2 He has an extensive background in the pharmaceutical and biotechnology industries, with experience in various leadership positions.
Professional Experience
Falkson's career trajectory includes:
- Gilgamesh Pharmaceuticals: Before becoming COO, he served as a Board Member and Senior Advisor from September 2019 to June 2021.2
- Regeneron: Held positions as Senior Director and Director of New Products Marketing and Planning.2
- SpringWorks Therapeutics: Co-founder of this company from July 2016 to June 2018.2
- Pfizer: Worked in roles such as Director of Global Commercial New Product Planning for CV/Metabolic and Director of Pricing and Reimbursement in the Primary Care Business Unit.2
Education
Falkson's educational background includes:
- An MBA from NYU Stern School of Business (2011-2014).2
- A degree in Economics and Psychology from Cornell University (2002-2006).2
Current Role
As COO of Gilgamesh Pharmaceuticals, Falkson is involved in the company's strategic operations and growth. The company has approximately 32 employees and generates around $5M in revenue.1 Gilgamesh Pharmaceuticals is involved in pharmaceutical development, with recent announcements including the successful completion of a clinical trial and the initiation of a Phase 2a study.34
Yoni Falkson's LinkedIn profile can be found at https://www.linkedin.com/in/yfalkson, where he is listed as having 500+ connections.2
